CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Geuder Pre-Loaded Glass Cannula
      • Ampho B
      • PKP
      • ALK
      • FLAK
      • VisionGraft
      • Sclera
    • Reimbursement Assistance
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Products
    • Products Overview
    • Corneal Products
      • EndoSerter-PL
      • EndoSerter
      • Cannula
      • Geuder Pre-Loaded Glass Cannula
      • Donor Punch
      • Recipient Trephine
      • Intacs
  • Innovation
  • Education
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Gift of Sight
    • Core Commitments
    • Careers
    • Our Locations
    • News & Events
Request Tissue Contact Us

Michael Banitt

September 25, 2020

Adding Ampho B to the medium is just one more way I know CorneaGen has the patient’s best interest in mind.

Recent Articles

  • Bernie’s Quarterly Update – September 2022

    Bernie’s Quarterly Update – September 2022

    We approach the end of another great quarter and exciting...

    READ MORE
  • Bernie’s Quarterly Update – June 2022

    Bernie’s Quarterly Update – June 2022

    It has been just over a year since I officially...

    READ MORE
  • CorneaGen Advances Next Generation of DSEK Surgery Innovation

    CorneaGen Advances Next Generation of DSEK Surgery Innovation

    New FDA approved, pre-loaded cornea graft insertion device maximizes efficiency...

    READ MORE
  • Ziemer USA Announces Partnership with CorneaGen

    Ziemer USA Announces Partnership with CorneaGen

    Ziemer USA, a wholly owned subsidiary of Switzerland-based Ziemer AG,...

    READ MORE
Navigation
  • Corneal Tissue
  • Products
  • Innovation
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Terms and conditions
  • Regulatory Information
Connect
  • Contact Us
CorneaGen

©2022 CorneaGen

CorneaGen